Intraday Stocks For Today: Eternal, REC, Adani Ports, Sun Pharma, Ashok Leyland & more
Intraday Stocks for Today: Eternal, REC, Adani Ports, Sun Pharma & Ashok Leyland – check live prices, targets, key updates, and trading insights.

Introduction
Intraday trading—buying and selling stocks within the same trading day—requires quick decisions, strong market intel, and awareness of short-term price drivers. Today, several large-cap and mid-cap names are under spotlight: Eternal (Zomato/Blinkit parent), REC, Adani Ports, Sun Pharma, Ashok Leyland, among others. Experts have issued targets and stop-losses for them. Let’s understand their recent history, where the stocks are, what to expect, whether they’re better for long-term investment or short-term trading, plus key points, drawbacks, and what these might mean.
History & Background
-
Eternal Ltd: Formerly known as Zomato/Blinkit parent, an e-commerce/quick commerce hybrid. It has seen strong revenue growth (~67% YoY) though with losses in EBIT, but statutory profit reports have emerged. Its PE ratio is high; the stock is growing rapidly.
-
REC (Rural Electrification Corporation): A government-backed finance/infra lending company; considered relatively stable, often used in PSU sector plays.
-
Adani Ports & SEZ: Major infrastructure/port operations company. Tends to be sensitive to trade, global shipping, economic growth, and regulatory/policy shifts.
-
Sun Pharma: One of India’s leading pharmaceutical companies. Historically strong earnings, global footprint, R&D, generics. Sensitive to regulatory environment, competition, patent issues.
-
Ashok Leyland: Leading commercial vehicle/automobile manufacturer, tied to cyclic economic demand (infrastructure, transportation, logistics, fleet purchasing, etc.).
Present (Intraday) Market Price & Targets
Based on recent expert recommendations (ET Now etc.):
Stock | Current Market Price (CMP) | Target Price / Stop Loss |
---|---|---|
Eternal | ~ ₹337.85 on NSE | Target: ~ ₹370, Stop-loss: ~ ₹324 |
REC | ~ ₹385 | Target ~ ₹402, Stop-loss ~ ₹374 |
Adani Ports | ~ ₹1,411 | Target ~ ₹1,550, Stop-loss ~ ₹1,370 |
Sun Pharma | ~ ₹1,648.50 | Target ~ ₹1,690, Stop-loss ~ ₹1,620 |
Ashok Leyland | ~ ₹138.90 | Target ~ ₹144, Stop-loss ~ ₹134 |
These are intraday trading suggestions—so price swings, volatility, and risk are higher.
What Becomes Expected High or Low
-
If stocks like Eternal, Adani Ports, etc., break above their target levels, they may test new support-/resistance zones. For example, Eternal’s 52-week high is ~ ₹338.50; a break above could give upside momentum.
-
Downside risk for these stocks tends to be their stop-loss levels. If they fall below stop loss, traders expect a drop toward support levels.
Long-Term vs Short-Term: Which Better?
-
Short-Term (Intraday): These stocks are good for intraday if you’re comfortable with volatility. Traders can use the target / stop loss values. Much depends on market events, global cues, and intra-day momentum.
-
Long-Term: Some look promising for long-term:
-
Eternal, if it can scale Blinkit / quick commerce margins and move toward profitability. But high valuation (PE) is a concern.
-
Adani Ports has infrastructure strength and growth tied to ports/static trade flows.
-
Sun Pharma has pharma sector tailwinds but also regulatory risks.
-
Ashok Leyland depends on economic growth, demand for transportation, inflation, input costs.
-
So, long-term may be viable for some of these, but only with tolerance for risk, clear understanding of fundamentals, valuation, competitive landscape.
Key Points & Drawbacks
Key Points / Advantages:
-
Strong short-term upside possibility with well defined target/stop loss.
-
Big names with existing liquidity, known businesses which reduces some unknowns.
-
Sectoral tailwinds: pharma demand, infrastructure growth, quick commerce (Eternal).
-
Some have potential for long-term appreciation if valuations normalize and earnings grow.
Drawbacks / Risks:
-
High valuations (especially Eternal) may mean the stock is overhyped and vulnerable in corrections.
-
Regulatory / policy risks (pharma, ports, trade) can have outsized effects.
-
Input cost inflation (fuel, raw materials) can hurt margins.
-
Volatility and possibility of large intraday losses if stop-losses are not adhered to.
-
Market sentiment shifts quickly; global macro (interest rates, dollar strength, trade disruptions) matter.
Latest Updates & Fresh Signals
-
Eternal’s share price has been rising recently; Goldman Sachs raised its target, noting Blinkit’s margin improvement and EBITDA breakeven potential by Dec 2025.
-
Some analysts have average targets for Eternal lower than current price, suggesting possible downside risk if momentum fades
-
Adani Ports continues to see interest; option chain activity suggests interest among derivatives traders.
Important & Significant Factors to Watch
-
Earnings announcements and guidance (especially for Eternal, Sun Pharma).
-
Policy / regulation changes (port policies, pharma pricing, trade barriers).
-
Global macro factors: interest rates, inflation, supply chain issues.
-
Margin improvements (for quick commerce, pharma, auto).
-
Input cost fluctuations (fuel, raw materials).
-
Competition from domestic/international players.
-
Volume / technical support/resistance levels in charts.
Final Thoughts & Conclusion
These stocks are interesting for intraday trading today given the expert recommendations with clear target/stop-loss levels. For traders, there’s a chance of profit if disciplined and following risk management. However, carryover risk is significant.
For long-term investors, some of these (Eternal, Adani Ports, Sun Pharma) may hold promise, provided earnings improve, valuations moderate, and business fundamentals remain intact. But Eternal’s extremely high PE suggests caution. Ashok Leyland and REC may be more stable value plays, though growth will depend heavily on the broader economy.
Conclusion: If you are a short-term trader, these stocks provide opportunity but also risk. Long-term investors should be selective—focus on fundamentals, margin trends, valuation, and stay cautious, especially for high valuation names. Always use stop-loss, diversify, and don’t base all your bets on hype.